vs

Side-by-side financial comparison of MediWound Ltd. (MDWD) and Where Food Comes From, Inc. (WFCF). Click either name above to swap in a different company.

Where Food Comes From, Inc. is the larger business by last-quarter revenue ($6.0M vs $5.7M, roughly 1.1× MediWound Ltd.). Where Food Comes From, Inc. runs the higher net margin — -3.4% vs -233.3%, a 230.0% gap on every dollar of revenue. On growth, MediWound Ltd. posted the faster year-over-year revenue change (12.7% vs -9.3%).

MediWound Ltd. is a biopharmaceutical company specializing in the research, development, production and commercialization of innovative products for burn care, chronic wound treatment and soft tissue repair. It operates mainly across North America, Europe and Asia, serving hospitals, healthcare providers and patients in the wound care segment.

Where Food Comes From, Inc. is a leading provider of food traceability, verification, and certification solutions for the agricultural and food production industries. Its services support producers, processors, and retailers across North America to validate food origin, sustainability practices, animal welfare standards, and product authenticity for end consumers.

MDWD vs WFCF — Head-to-Head

Bigger by revenue
WFCF
WFCF
1.1× larger
WFCF
$6.0M
$5.7M
MDWD
Growing faster (revenue YoY)
MDWD
MDWD
+22.0% gap
MDWD
12.7%
-9.3%
WFCF
Higher net margin
WFCF
WFCF
230.0% more per $
WFCF
-3.4%
-233.3%
MDWD

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
MDWD
MDWD
WFCF
WFCF
Revenue
$5.7M
$6.0M
Net Profit
$-13.3M
$-203.0K
Gross Margin
23.5%
35.9%
Operating Margin
-100.1%
-1.0%
Net Margin
-233.3%
-3.4%
Revenue YoY
12.7%
-9.3%
Net Profit YoY
-111.2%
-121.1%
EPS (diluted)
$-1.23
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDWD
MDWD
WFCF
WFCF
Q4 25
$6.0M
Q3 25
$7.0M
Q2 25
$5.7M
$6.6M
Q1 25
$5.3M
Q4 24
$6.7M
Q3 24
$7.1M
Q2 24
$5.1M
$6.4M
Q1 24
$5.6M
Net Profit
MDWD
MDWD
WFCF
WFCF
Q4 25
$-203.0K
Q3 25
$1.1M
Q2 25
$-13.3M
$562.0K
Q1 25
$31.0K
Q4 24
$961.0K
Q3 24
$492.0K
Q2 24
$-6.3M
$489.0K
Q1 24
$178.0K
Gross Margin
MDWD
MDWD
WFCF
WFCF
Q4 25
35.9%
Q3 25
38.3%
Q2 25
23.5%
37.5%
Q1 25
41.6%
Q4 24
42.0%
Q3 24
39.0%
Q2 24
8.8%
41.6%
Q1 24
41.7%
Operating Margin
MDWD
MDWD
WFCF
WFCF
Q4 25
-1.0%
Q3 25
8.2%
Q2 25
-100.1%
8.4%
Q1 25
2.7%
Q4 24
11.3%
Q3 24
8.6%
Q2 24
-88.6%
9.1%
Q1 24
4.7%
Net Margin
MDWD
MDWD
WFCF
WFCF
Q4 25
-3.4%
Q3 25
16.3%
Q2 25
-233.3%
8.6%
Q1 25
0.6%
Q4 24
14.4%
Q3 24
6.9%
Q2 24
-124.5%
7.6%
Q1 24
3.2%
EPS (diluted)
MDWD
MDWD
WFCF
WFCF
Q4 25
$-0.04
Q3 25
$0.22
Q2 25
$-1.23
$0.11
Q1 25
$0.01
Q4 24
$0.19
Q3 24
$0.09
Q2 24
$-0.68
$0.09
Q1 24
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDWD
MDWD
WFCF
WFCF
Cash + ST InvestmentsLiquidity on hand
$1.1M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.1M
$9.3M
Total Assets
$67.0M
$12.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDWD
MDWD
WFCF
WFCF
Q4 25
$3.2M
Q3 25
$4.8M
Q2 25
$1.1M
$3.2M
Q1 25
$2.2M
Q4 24
$2.0M
Q3 24
$2.8M
Q2 24
$3.8M
$2.6M
Q1 24
$1.9M
Stockholders' Equity
MDWD
MDWD
WFCF
WFCF
Q4 25
$9.3M
Q3 25
$10.3M
Q2 25
$20.1M
$10.0M
Q1 25
$9.6M
Q4 24
$9.9M
Q3 24
$9.5M
Q2 24
$17.9M
$9.7M
Q1 24
$9.6M
Total Assets
MDWD
MDWD
WFCF
WFCF
Q4 25
$12.9M
Q3 25
$16.9M
Q2 25
$67.0M
$16.6M
Q1 25
$15.2M
Q4 24
$15.3M
Q3 24
$16.9M
Q2 24
$57.3M
$16.8M
Q1 24
$15.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDWD
MDWD
WFCF
WFCF
Operating Cash FlowLast quarter
$-5.8M
$-707.0K
Free Cash FlowOCF − Capex
$-741.0K
FCF MarginFCF / Revenue
-12.3%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDWD
MDWD
WFCF
WFCF
Q4 25
$-707.0K
Q3 25
$501.0K
Q2 25
$-5.8M
$1.2M
Q1 25
$632.0K
Q4 24
$-50.0K
Q3 24
$912.0K
Q2 24
$-3.6M
$1.2M
Q1 24
$700.0K
Free Cash Flow
MDWD
MDWD
WFCF
WFCF
Q4 25
$-741.0K
Q3 25
$443.0K
Q2 25
$1.1M
Q1 25
$603.0K
Q4 24
$-79.0K
Q3 24
$873.0K
Q2 24
$1.1M
Q1 24
$676.0K
FCF Margin
MDWD
MDWD
WFCF
WFCF
Q4 25
-12.3%
Q3 25
6.3%
Q2 25
17.5%
Q1 25
11.4%
Q4 24
-1.2%
Q3 24
12.3%
Q2 24
17.2%
Q1 24
12.1%
Capex Intensity
MDWD
MDWD
WFCF
WFCF
Q4 25
0.6%
Q3 25
0.8%
Q2 25
0.5%
Q1 25
0.5%
Q4 24
0.4%
Q3 24
0.5%
Q2 24
1.0%
Q1 24
0.4%
Cash Conversion
MDWD
MDWD
WFCF
WFCF
Q4 25
Q3 25
0.44×
Q2 25
2.10×
Q1 25
20.39×
Q4 24
-0.05×
Q3 24
1.85×
Q2 24
2.39×
Q1 24
3.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDWD
MDWD

Segment breakdown not available.

WFCF
WFCF

Verification And Certification Service Revenue$5.0M83%
Other$1.0M17%

Related Comparisons